Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression.Published in:EMBO Molecular Medicine, 2024, v. 16, n. 6, p. 1379, doi. 10.1038/s44321-024-00071-9By:Clerici, Sara;Podrini, Christine;Stefanoni, Davide;Distefano, Gianfranco;Cassina, Laura;Steidl, Maria Elena;Tronci, Laura;Canu, Tamara;Chiaravalli, Marco;Spies, Daniel;Bell 3rd, Thomas A;Costa, Ana SH;Esposito, Antonio;D'Alessandro, Angelo;Frezza, Christian;Bachi, Angela;Boletta, AlessandraPublication type:Article